Connect with us

health

Nnamdi Azikiwe University Teaching Hospital confirms first case of COVID-19

Published

Authorities of the Nnamdi Azikiwe University Teaching Hospital (NAUTH), Nnewi, have confirmed that one case of coronavirus has been recorded in the hospital.

Prof. Anthony Igwegbe, the Chief Medical Director (CMD) of the hospital, disclosed this on Monday, NAN reports.

Igwegbe said the patient was diagnosed with the virus following a test upon getting to the hospital.

According to him, the test result was released on May 23.

MORE READING!  JUST IN: Fire guts CBN branch in Gombe

He also said that the patient was immediately moved to one of the isolation centres in Anambra State for treatment.

He said,

“The patient was quickly moved from our isolation ward to the Anambra State Treatment Centre last night for care and treatment.

“The patient, a male trader resident in Onitsha was admitted to the isolation ward following proper triage on his presentation on May 20.

“Specimen for test was taken the following day and sent to Irrua.”

The CMD further stated that a suspect was earlier taken in, but test sample was not taken before the patient died.

“That was a probable case, the patient showed some symptoms but sample was not taken before the patient died.

“So we have only one confirmed case of COVID-19 in NAUTH so far,” he added.

However, he said that all the necessary precautions were taken and all those that attended to the confirmed patient used Personal Protection Equipment.

MORE READING!  Ondo First Lady, security aide test positive for COVID-19

He also gave an assurance that the hospital would remain vigilant.

health

American don donates surgical instruments to Unilorin

Published

on

The University of Ilorin (Unilorin) has hailed an American don, Emeritus Prof. Eugene Myers, for donating equipment worth thousands of dollars to its Otorhinolaryngology (ORL) Department.

In a statement signed by Prof. Busari Alabi, the ORL Course Coordinator in Unilorin, the university said that the high-quality instruments are known as German products – Karl Storzwill – would be of immense use for patients’ care and medical education.

MORE READING!  Ondo First Lady, security aide test positive for COVID-19

According to the university, Myers is of the ORL Department of the University of Pittsburgh School of Medicine in the U.S.

“The equipment will be used for cadaver dissections and elective surgery.

“Myers is an expert who has played leadership roles in most of the professional and scientific societies in the field of Head and Neck Surgery.

MORE READING!  JUST IN: Fire guts CBN branch in Gombe

“He was awarded a gold medal for his international activities at the 2009 IFOS World Congress, and currently serves as the Honorary President of the Balkan Society of Otolaryngology.

” Furthermore, he is the Regional Advisor to the Balkans for the American Academy of Otolaryngology-Head and Neck Surgery,” Unilorin said.

He added that Myers had served on the boards of many non-profit organizations, including Pennsylvania Lions Hearing Research Foundation and Support for People with Oral, Head and Neck Cancer, among others. (NAN)

MORE READING!  Osun records 24 new coronavirus cases
Continue Reading

health

Kwara govt acquires two state-of-the-art ambulances for emergency response

Published

on

The Kwara State Government has acquired two state-of-the-art Mercedes Benz Ambulances to boost emergency response system in the state.

The Newsmen reports that the ambulances were unveiled on Sunday at a brief ceremony in the Government House premises, Ilorin.

Inspecting the two new ambulances, Gov. AbdulRahman AbdulRazaq, reassured of his administration’s commitment to a full-blown turnaround in the Kwara Health system.

MORE READING!  Nigeria records 626 new COVID-19 cases, total now 27,110

AbdulRazaq said that the gesture was another step in his administration’s drive to improve healthcare delivery, saying more were in the offing after the end of the COVID-19 pandemic.

The governor commended health workers in the state for putting a strong fight for the survival of COVID-19 patients, saying that their calling was service to humanity.

MORE READING!  Ebonyi governor's coronavirus test result out today, to handover to deputy if positive

The state Commissioner for Health, Dr. Raji Razaq, who took the governor round the ambulances, described the gesture as another feather to the cap of the ministry; noting that it was a promise kept for strengthening the health system in the state.

He noted that the two high-roofed ambulances were fully equipped with resuscitative gadgets, oxygen, and ventilators to keep patients alive.

MORE READING!  JUST IN: Fire guts CBN branch in Gombe
Continue Reading

health

WHO discontinues trial of hydroxychloroquine treatment for COVID-19 patients

Published

on

The World Health Organisation (WHO) says it has discontinued the use of hydroxychloroquine and lopinavir/ritonavir in its global trial for the treatment of COVID-19 as recommended by the Solidarity Trial’s International Steering Committee.

The UN health agency, in a statement posted on its website, stated that the Solidarity Trial was established by WHO to find an effective COVID-19 treatment for hospitalized patients.

“The committee formulated the recommendation in light of the evidence for hydroxychloroquine vs standard-of-care and for lopinavir/ritonavir vs standard-of-care from the Solidarity trial interim results.

“The trial interim results and from a review of the evidence from all trials presented at the July 1 to July 2, WHO Summit on COVID-19 research and innovation.

“These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care.

“Solidarity trial investigators will interrupt the trials with immediate effect,’’ it said.

According to the statement, for each of the drugs, the interim results do not provide solid evidence of increased mortality.

“There were, however, some associated safety signals in the clinical laboratory findings of the add-on Discovery trial, a participant in the Solidarity trial.

“These will also be reported in the peer-reviewed publication.

“This decision applies only to the conduct of the Solidarity trial in hospitalized patients and does not affect the possible evaluation in other studies of hydroxychloroquine or lopinavir/ritonavir in non-hospitalized patients or as pre- or post-exposure prophylaxis for COVID-19.

“The interim Solidarity results are now being readied for peer-reviewed publication.’

MORE READING!  Ondo Health Commissioner dies of COVID-19
Continue Reading




Trending